ESMERALDA HOWARD: Open Payments
NPI 1144428558 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,537 in 63 payments from 12 companies in 2025. Trend: 2023 $651 · 2024 $795 · 2025 $1,537
Food & beverage: $1,537
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 15 | $393 |
| Ipsen Biopharmaceuticals, Inc | 10 | $328 |
| ABBVIE INC. | 10 | $214 |
| Madrigal Pharmaceuticals | 8 | $195 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $138 |
| Intercept Pharmaceuticals, Inc. | 3 | $75 |
| Mirum Pharmaceuticals, Inc. | 3 | $59 |
| ORPHALAN INC | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 2 | $32 |
| Eton Pharmaceuticals, Inc. | 1 | $23 |
Products named: IQIRVO, MAVYRET, REZDIFFRA, XIFAXAN, Livdelzi, OCALIVA, Livmarli, CUVRIOR.
Industry payments across TX — which companies pay providers there.
